Bio-Path Holdings Reports Second Quarter 2020 Financial Results

NEXT STORY
ContraFect Reports Second Quarter 2020 Financial Results and Provides Business Update
PREV STORY
Global Infectious Disease Diagnostics Market, Forecast to 2027
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Revive Therapeutics Announces Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

author_avatar
NASDAQ Market News

Atos and Huma enter into five-year partnership to improve healthcare and research with innovative remote monitoring technologies

author_avatar
NASDAQ Market News

Results from Phase 1 Study of CB-839 in Combination with Capecitabine in Advanced Solid Tumors to be Presented at the 2018 American Society of Clinical Oncology (ASCO)

Phase 2 to Continue Enrolling Colorectal Cancer Patients with PIK3CA Mutation SOUTH SAN FRANCISCO, ...

author_avatar
NASDAQ Market News